You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 6,103,515


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,103,515
Title: Production of polypeptides by use of novel protease deficient yeast strains
Abstract:A novel process for the production of heterologous proteins including the use of certain transformed protease deficient yeast strains is provided. The invention concerns also said transformed yeast strains and methods for the production thereof.
Inventor(s): Treichler; Hansjorg (Kanerkinden, CH), Takabayashi; Kenji (Basel, CH), Wolf; Dieter Heinrich (Gundelfingen, DE), Heim; Jutta (Ramlinsburg, CH)
Assignee: Novartis Corporation (New York, NY) UCP Gen-Pharma AG (Kirchberg, CH)
Application Number:07/895,581
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 6,103,515

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,103,515

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8810524May 04, 1988
United Kingdom8812627May 27, 1988
United Kingdom8907110Mar 29, 1989

International Family Members for US Patent 6,103,515

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 124086 ⤷  Try a Trial
Australia 3382889 ⤷  Try a Trial
Australia 614121 ⤷  Try a Trial
Canada 1340016 ⤷  Try a Trial
German Democratic Republic 283839 ⤷  Try a Trial
Germany 68923123 ⤷  Try a Trial
Denmark 175701 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.